Cargando…
Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity
Obesity is characterized by an excessive accumulation of fat leading to a plethora of medical complications, including coronary artery disease, hypertension, type 2 diabetes mellitus or impaired glucose tolerance and dyslipidemia. Formerly, several physiological roles of organokines, including adipo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967669/ https://www.ncbi.nlm.nih.gov/pubmed/36837889 http://dx.doi.org/10.3390/metabo13020270 |
_version_ | 1784897322485809152 |
---|---|
author | Lőrincz, Hajnalka Somodi, Sándor Ratku, Balázs Harangi, Mariann Paragh, György |
author_facet | Lőrincz, Hajnalka Somodi, Sándor Ratku, Balázs Harangi, Mariann Paragh, György |
author_sort | Lőrincz, Hajnalka |
collection | PubMed |
description | Obesity is characterized by an excessive accumulation of fat leading to a plethora of medical complications, including coronary artery disease, hypertension, type 2 diabetes mellitus or impaired glucose tolerance and dyslipidemia. Formerly, several physiological roles of organokines, including adipokines, hepatokines, myokines and gut hormones have been described in obesity, especially in the regulation of glucose and lipid metabolism, insulin sensitivity, oxidative stress, and low-grade inflammation. The canonical effect of these biologically active peptides and proteins may serve as an intermediate regulatory level that connects the central nervous system and the endocrine, autocrine, and paracrine actions of organs responsible for metabolic and inflammatory processes. Better understanding of the function of this delicately tuned network may provide an explanation for the wide range of obesity phenotypes with remarkable inter-individual differences regarding comorbidities and therapeutic responses. The aim of this review is to demonstrate the role of organokines in the lipid and glucose metabolism focusing on the obese non-diabetic subgroup. We also discuss the latest findings about sarcopenic obesity, which has recently become one of the most relevant metabolic disturbances in the aging population. |
format | Online Article Text |
id | pubmed-9967669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99676692023-02-27 Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity Lőrincz, Hajnalka Somodi, Sándor Ratku, Balázs Harangi, Mariann Paragh, György Metabolites Review Obesity is characterized by an excessive accumulation of fat leading to a plethora of medical complications, including coronary artery disease, hypertension, type 2 diabetes mellitus or impaired glucose tolerance and dyslipidemia. Formerly, several physiological roles of organokines, including adipokines, hepatokines, myokines and gut hormones have been described in obesity, especially in the regulation of glucose and lipid metabolism, insulin sensitivity, oxidative stress, and low-grade inflammation. The canonical effect of these biologically active peptides and proteins may serve as an intermediate regulatory level that connects the central nervous system and the endocrine, autocrine, and paracrine actions of organs responsible for metabolic and inflammatory processes. Better understanding of the function of this delicately tuned network may provide an explanation for the wide range of obesity phenotypes with remarkable inter-individual differences regarding comorbidities and therapeutic responses. The aim of this review is to demonstrate the role of organokines in the lipid and glucose metabolism focusing on the obese non-diabetic subgroup. We also discuss the latest findings about sarcopenic obesity, which has recently become one of the most relevant metabolic disturbances in the aging population. MDPI 2023-02-14 /pmc/articles/PMC9967669/ /pubmed/36837889 http://dx.doi.org/10.3390/metabo13020270 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lőrincz, Hajnalka Somodi, Sándor Ratku, Balázs Harangi, Mariann Paragh, György Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity |
title | Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity |
title_full | Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity |
title_fullStr | Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity |
title_full_unstemmed | Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity |
title_short | Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity |
title_sort | crucial regulatory role of organokines in relation to metabolic changes in non-diabetic obesity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967669/ https://www.ncbi.nlm.nih.gov/pubmed/36837889 http://dx.doi.org/10.3390/metabo13020270 |
work_keys_str_mv | AT lorinczhajnalka crucialregulatoryroleoforganokinesinrelationtometabolicchangesinnondiabeticobesity AT somodisandor crucialregulatoryroleoforganokinesinrelationtometabolicchangesinnondiabeticobesity AT ratkubalazs crucialregulatoryroleoforganokinesinrelationtometabolicchangesinnondiabeticobesity AT harangimariann crucialregulatoryroleoforganokinesinrelationtometabolicchangesinnondiabeticobesity AT paraghgyorgy crucialregulatoryroleoforganokinesinrelationtometabolicchangesinnondiabeticobesity |